Cannabis Law Report

JUNE 29, 2021

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools. Ehave, Inc.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. Virtual Clinical Trials transcend geographic, mobility and economic barriers. Authored By : Arundati Dandapani.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JANUARY 14, 2022

BusinessCann UK reports that the UK Medical Cannabis Bill has Buckley’s chance. THE Member of Parliament sponsoring the Medical Cannabis Access Bill in the House of Commons today has acknowledged it is set to fail due to lack of political support. Cannabis Trials.

Access 52

Access Clinical Trials Patients Cannabis 52

Cannabis Law Report

FEBRUARY 24, 2022

Thus, providing a new pathway for patients to access psychedelic treatment, and another example of the medicinal approach to psychedelic legalization. Each request is decided on a patient-by-patient basis and approval is usually only given to drugs with successful phase II or phase II clinical trials.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Americans for Safe Access

JUNE 2, 2020

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

Clinical Trials 230

Clinical Trials DEA History Programs 230

Cannabis Law Report

JUNE 3, 2021

This week, the suing parties filed an Opening Brief in the Ninth Circuit Court of Appeals arguing that under the state and federal Right to Try Act seriously ill patients have a right to use medicines that are currently undergoing clinical trials, such as psilocybin (the active compound in magic mushrooms) and MDMA. Read more .

DEA 98

DEA Access Clinical Trials Patients 98

Cannabis Law Report

JANUARY 11, 2022

Legal cannabis partnership to help patient access. The new distributor in the Australian medicinal cannabis industry – The Entourage Effect – has signed a firstof its kind deal with innovative medical cannabis clinic MiDispensary. UPDATED : Wednesday 12th of January 2022. SYDNEY, AUSTRALIA –.

Access 52

Access Patients Clinical Trials Legalization 52

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

NORML

APRIL 30, 2020

.” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5

Chronic Pain 341

Chronic Pain Clinical Trials Data Patients 341

Veriheal

MARCH 2, 2024

When it comes to cannabis in Japan, the country is known for maintaining strict prohibition and regulation of cannabis-derived products. The revised legislation would permit clinical use and production of cannabis for medical CBD products, like Epidiolex , that have been approved in the U.S.

Legalization 108

Legalization Epilepsy Clinical Trials THC 108

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. Misleading claims represent both a threat to public health and a violation of consumer access to accurate information.”

CBD 295

CBD Clinical Trials Data Treatment 295

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). Twenty percent of those surveyed acknowledged having previously used cannabis for medical purposes.

Clinical Trials 193

Clinical Trials Chronic Pain Data Treatment 193

Cannabis Law Report

MARCH 30, 2022

Legislation unanimously passed by members of the US Senate empowers the US Attorney General to facilitate clinical research trials involving cannabis. NORML write. The action represents one of the very few occasions that members of the Senate have ever advanced a marijuana-related reform bill.

Legislation 95

Legislation Clinical Trials DEA Access 95

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. None of it was initially slated to go to clinical trials. The deadline for proposals is Friday, July 16. Read more at.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JULY 15, 2021

Completion of acquisition provides Creso Pharma with access to the emerging global market for psychedelic medicines – estimated to be worth up to US100Bni. ? Halucenex to progress phase II clinical trial to test the efficacy of psilocybin when used to treat Post Traumatic Stress Disorder (PTSD). ? Highlights: ? The full release.

Clinical Trials 96

Clinical Trials Therapy Treatment Access 96

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. Medicinal cannabis products have been available since 2018. million patients currently accessing cannabis through the illicit market.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

AUGUST 7, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. European Regulatory Lead Executive Summary. Key Responsibilities.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

The Cannigma

JUNE 10, 2021

The Cannabis Enigma Podcast is wrapping up its first season. The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. The post Season finale: Best of The Cannabis Enigma podcast appeared first on The Cannigma. Michael Schaeffer Omer-Man is the executive producer, editor, and co-host.

Clinical Trials 82

Clinical Trials Access Cannabis Patients 82

Cannabis Law Report

MARCH 7, 2022

A contemporary history of the remedicalization of cannabis and the shifting boundaries between licit and illicit drugs. When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic.

Clinical Trials 52

Clinical Trials Policy History Epilepsy 52

Cannabis Law Report

AUGUST 10, 2022

According to CAMH’s lead investigator, clinical trials suggest that psilocybin, combined with psychotherapy, can produce “ sustained antidepressant effects” in individuals living with severe depression.

Clinical Trials 52

Clinical Trials Research and Development Therapy Microdosing 52

Cannabis Law Report

JUNE 14, 2022

There are multiple clinical centers doing research with psychedelics in Europe and, inevitably, regulatory approvals in Europe will follow. However, there is a growing realization that European health systems may not be prepared for these treatments.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

DECEMBER 5, 2021

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Cannabis Law Report

JUNE 20, 2021

Here’s the press release… Elisabetta Faenza has been elected to the UK-based Cannabis Industry Council (CIC) Board and has been selected to Chair its Standards Group. Patient access.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

Cannabis Law Report

AUGUST 30, 2021

AMC will use the products in clinical trials as well as help ‘seek US regulatory approvals for all products which they intend to distribute’. Co-founder and Managing Director of MGC Pharma Roby Zomer believes this is a turning point for the company, allowing it to access one of the largest healthcare markets in the world.

Clinical Trials 105

Clinical Trials Access 105

Cannabis Law Report

DECEMBER 15, 2021

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. “I agree with the committee that the preliminary findings from clinical trials — although still in early phases — evaluated by the panel are promising,” the decision’s author said.

Clinical Trials 52

Clinical Trials Conditions Supply Chain Environment 52

Veriheal

MARCH 20, 2023

While decriminalization decreases the negative impact of legal issues, it does not provide accessible, safe, and regulated psilocybin for those seeking treatment. Andy Smith (D) stated that he is “working on a bill forming a psychedelic medicine task force so Minnesotans can access these life-affirming treatments. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Though, Oregon is actively in the process of establishing a model for psilocybin that would be like the state’s current medical cannabis system. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

NORML

OCTOBER 21, 2019

A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.

DEA 104

DEA Cultivation Clinical Trials Policy 104

Cannabis Law Report

JUNE 21, 2021

In the medical cannabis industry, mostly due to the plant’s long history of prohibition, there is a decided lack of data regarding the use and efficacy of cannabis as a treatment for a wide variety of indications. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

NOVEMBER 7, 2021

WA Upper House MP Brian Walker is in the spotlight over potential conflict of interests concerns after he was appointed ‘strategic consultant’ to an ASX-listed medicinal cannabis company. Legalise Cannabis WA MP Brian Walker denies conflict over medicinal cannabis company. Cannabiz reported Friday.

Medicine 52

Medicine Clinical Trials Research and Development Pharmaceutical 52

Veriheal

FEBRUARY 9, 2023

A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures. All imaging and behavioral data will be accessible to the public after the study is complete. What Is an MRI?

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98